Started December 1, 1988, World AIDS Day annually raises awareness of the AIDS pandemic and is a day to mourn those who have died of the disease. The World Health Organization chose to focus on “Global solidarity, resilient HIV services” as its theme for this year. As of 2019 there were 38 million people living […]
BC-CfE Marks Record Achievements for World AIDS Day 2020 Read More »
The fitting theme of AIDS 2020, the first fully-virtual International AIDS Conference, was Resilience. The theme reminded the global HIV community of its ability to come together despite a global pandemic to share our commitment to HIV prevention, treatment and cure research. More than 180 countries participated in this year’s conference, held during the second
BC-CfE contributes to vital dialogue at a virtual 23rd International AIDS Conference Read More »
On Sunday December 1, 2019, World AIDS Day, the Minister of Health Adrian Dix and the BC Centre for Excellence in HIV/AIDS (BC-CfE) announced the end of AIDS as an epidemic in British Columbia (BC). The announcement was made along with the opening of the BC-CfE’s new laboratory on Powell Street. The new BC-CfE Research
BC first province to declare the End of AIDS as an Epidemic Read More »
“It’s extraordinary story,” begins Dr. Zabrina Brumme, Laboratory Director at the BC Centre for Excellence in HIV/AIDS (BC-CfE) and Professor of Health Sciences at SFU. Timothy Brown, known worldwide as the “Berlin patient” and the first person to be cured of HIV, was introduced by Dr. Brumme to a conference room in Vancouver. Attendees included
On April 24th, Federal Health Minister Hon. Ginette Petitpas Taylor visited the BC Centre for Excellence in HIV/AIDS (BC-CfE) to speak to Executive Director & Physician-in-Chief Dr. Julio Montaner about BC’s leadership in HIV, hepatitis C (HCV) and opioid use disorder (OUD). The BC-CfE has long played an essential role in the testing, diagnosis, treatment
Made-in-BC Treatment as Prevention strategy recognized locally, nationally and globally Read More »
The BC-CfE applauds the news that emerged from CROI (Conference on Retroviruses and Opportunistic Infections) and captured global news headlines: an individual living with HIV has been in remission and off treatment for 18 months after receiving a bone-marrow transplant. The “London patient” is now the second individual to achieve HIV remission. To briefly explain,
Countering complacency on path to an HIV cure Read More »
On January 17th, the BC-CfE announced the launch of a provincewide initiative, supported by a funding grant from Health Canada’s Substance Use and Addiction Program. The first-of-its-kind initiative based on the BC-CfE’s world-renowned Treatment as Prevention (TasP) strategy to curb HIV and AIDS—will roll out across all BC regional health authorities in early 2019. This
China is facing an HIV epidemic that is on the scale of its population of approximately 1.4 billion. The BC-CfE is providing valuable insights on successful tactics, programs and strategies implemented in British Columbia to curb HIV. Namely, the BC-CfE’s Treatment as Prevention (TasP) strategy has transformed the province from the one with the highest
China CDC and BC-CfE renewed partnership reaffirms commitment to fight HIV Read More »
Just two years ago, UNAIDS announced a window of opportunity to end the AIDS epidemic by 2030 by fast-tracking towards meeting the 90-90-90 Target. There was tempered optimism this ambitious goal was within reach. Now, the international HIV community is experiencing a sense of urgency: complacency is moving us perilously close to an HIV rebound.
Are we close to the end of AIDS? Read More »
The first time Dr. Zabrina Brumme entered the BC Centre for Excellence in HIV/AIDS (BC-CfE), she had no idea she would one day be the director of its innovative Laboratory Program. She was only seventeen at the time and had not yet embarked on a career in HIV research that would introduce her to many
Dr. Zabrina Brumme to lead world-renowned BC-CfE Laboratory Program Read More »
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
